{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T17:06:06Z","timestamp":1784567166980,"version":"3.55.0"},"reference-count":43,"publisher":"Bioscientifica","issue":"7","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Patients with endogenous Cushing\u2019s syndrome (CS) exhibit reduced muscle strength compared with healthy individuals and frequently experience a further postoperative decline despite remission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the histological and immunohistochemical patterns underlying myopathy in patients with active and remitted CS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>We included nine patients with active CS and eight patients with CS in remission, prospectively enrolled at LMU Hospital. Patients in remission had curative tumor surgery and biochemical remission for \u226524 months. Biopsies of the vastus lateralis muscle were obtained surgically and analyzed by histology, immunohistochemistry and electron microscopy. IGF-1 concentrations were determined using an IDS-iSYS analyzer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In active CS, the mean cross-sectional area of type II muscle fibers was reduced. Nicotinamide adenine dinucleotide staining revealed mild moth-eaten fiber patterns in four patients, accompanied by ultrastructural pathologies on electron microscopy, including increased subsarcolemmal mitochondrial aggregates that were also present in remitted CS. In active CS, circulating absolute IGF-1 concentrations positively (rs = 0.8, P = 0.014) and age inversely (rs = \u22120.77, P = 0.021) correlated with mean cross-sectional area of type II muscle fibers. In remission from CS, type II fiber atrophy was not present in most patients. No substantial associations were found between the severity of glucocorticoid excess and histological alterations during active or remitted disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Active CS is characterized by type II fiber atrophy and is associated with circulating IGF-1 and age. In remission, type II fiber atrophy was not present, whereas mitochondrial ultrastructural alterations could be observed. These findings indicate sustained muscle alterations and highlight the need for mechanistic studies to guide targeted therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/ec-26-0355","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:52:49Z","timestamp":1783529569000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":0,"title":["Myopathy in endogenous Cushing\u2019s syndrome: type II muscle fiber atrophy and its association with age and circulating IGF-1"],"prefix":"10.1530","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6623-2900","authenticated-orcid":true,"given":"Moritz","family":"Schrenk","sequence":"first","affiliation":[{"name":"Department of Medicine IV, LMU University Hospital, LMU Munich 1 , ,","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Nowak","sequence":"additional","affiliation":[{"name":"Department of Medicine IV, LMU University Hospital, LMU Munich 1 , ,","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Vogel","sequence":"additional","affiliation":[{"name":"Department of Medicine IV, LMU University Hospital, LMU Munich 1 , ,","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Kr\u00fcger","sequence":"additional","affiliation":[{"name":"Department of Medicine IV, LMU University Hospital, LMU Munich 1 , ,","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"St\u00fcfchen","sequence":"additional","affiliation":[{"name":"Department of Medicine IV, LMU University Hospital, LMU Munich 1 , ,","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Oettle","sequence":"additional","affiliation":[{"name":"Department of Medicine IV, LMU University Hospital, LMU Munich 1 , ,","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugce","family":"Apaydin","sequence":"additional","affiliation":[{"name":"Acibadem Atasehir Hospital, Department of Endocrinology 2 , ,","place":["Istanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9078-5168","authenticated-orcid":true,"given":"Malgorzata","family":"Bobrowicz","sequence":"additional","affiliation":[{"name":"Medical University of Warsaw 3 , ,","place":["Warsaw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4681-6668","authenticated-orcid":true,"given":"Martin","family":"Bidlingmaier","sequence":"additional","affiliation":[{"name":"Department of Medicine IV, LMU University Hospital, LMU Munich 1 , ,","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Garcia-Angarita","sequence":"additional","affiliation":[{"name":"Friedrich-Baur-Institut, LMU University Hospital, LMU Munich 4 , ,","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna M","family":"Hofmann","sequence":"additional","affiliation":[{"name":"Department of Medicine IV, LMU University Hospital, LMU Munich 1 , ,","place":["Munich, Germany"]},{"name":"Helmholtz Munich 5 , ,","place":["Neuherberg, Germany"]},{"name":"German Center for Diabetes Research 6 , ,","place":["Neuherberg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia M","family":"Dinges","sequence":"additional","affiliation":[{"name":"Helmholtz Munich 5 , ,","place":["Neuherberg, Germany"]},{"name":"Technical University of Munich, TUM School of Medicine and Health, Department for Preventive Sports Medicine and Sports Cardiology, TUM University Hospital 7 , ,","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7469-6069","authenticated-orcid":true,"given":"Nicole","family":"Reisch","sequence":"additional","affiliation":[{"name":"Department of Medicine IV, LMU University Hospital, LMU Munich 1 , ,","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Siebenb\u00fcrger","sequence":"additional","affiliation":[{"name":"MUM-Muskuloskelettales Universit\u00e4tszentrum M\u00fcnchen, LMU University Hospital, LMU Munich 8 , ,","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Halle","sequence":"additional","affiliation":[{"name":"Technical University of Munich, TUM School of Medicine and Health, Department for Preventive Sports Medicine and Sports Cardiology, TUM University Hospital 7 , ,","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[{"name":"Department of Medicine IV, LMU University Hospital, LMU Munich 1 , ,","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Schoser","sequence":"additional","affiliation":[{"name":"Friedrich-Baur-Institut, LMU University Hospital, LMU Munich 4 , ,","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"2026072012463745600_bib1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/jama.2023.11305","article-title":"Cushing syndrome: a review","volume":"330","author":"Reincke","year":"2023","journal-title":"JAMA"},{"key":"2026072012463745600_bib2","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1210\/jc.2018-02524","article-title":"Overall and disease-specific mortality in patients with cushing disease: a Swedish nationwide study","volume":"104","author":"Ragnarsson","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2026072012463745600_bib3","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S2213-8587(16)30005-5","article-title":"Mortality in patients with Cushing\u2019s disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study","volume":"4","author":"Clayton","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026072012463745600_bib4","doi-asserted-by":"crossref","first-page":"M133","DOI":"10.1530\/EJE-15-0354","article-title":"Metabolic comorbidities in Cushing\u2019s syndrome","volume":"173","author":"Ferra\u00f9","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"2026072012463745600_bib5","first-page":"2664","article-title":"Persistence of increased cardiovascular risk in patients with Cushing\u2019s disease after five years of successful cure","volume":"84","author":"Colao","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2026072012463745600_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13113","article-title":"Long-term morbidity and mortality in patients with Cushing\u2019s syndrome","volume":"34","author":"Braun","year":"2022","journal-title":"J Neuroendocrinol"},{"key":"2026072012463745600_bib7","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/ejendo\/lvae097","article-title":"Prevalence and outcome of secondary hypogonadism in male patients with Cushing\u2019s syndrome and mild autonomous cortisol secretion","volume":"191","author":"Nowak","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"2026072012463745600_bib8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/ejendo\/lvae127","article-title":"Frequency of clinical signs in patients with Cushing\u2019s syndrome and mild autonomous cortisol secretion: overlap is common","volume":"191","author":"Braun","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"2026072012463745600_bib9","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1530\/EJE-16-0689","article-title":"Persistence of myopathy in Cushing\u2019s syndrome: evaluation of the German Cushing\u2019s Registry","volume":"176","author":"Berr","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"2026072012463745600_bib10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12020-017-1472-5","article-title":"Diagnostic work-up in steroid myopathy","volume":"60","author":"Minetto","year":"2018","journal-title":"Endocrine"},{"key":"2026072012463745600_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2021.101505","article-title":"Quality of life in Cushing\u2019s syndrome","volume":"35","author":"Bride","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2026072012463745600_bib12","doi-asserted-by":"crossref","first-page":"e4490","DOI":"10.1210\/clinem\/dgaa625","article-title":"Persisting muscle dysfunction in Cushing\u2019s syndrome despite biochemical remission","volume":"105","author":"Vogel","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2026072012463745600_bib13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1530\/EJE-20-1285","article-title":"Patients with low IGF-I after curative surgery for Cushing\u2019s syndrome have an adverse long-term outcome of hypercortisolism-induced myopathy","volume":"184","author":"Vogel","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"2026072012463745600_bib14","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2026072012463745600_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1748-1716.1983.tb07185.x","article-title":"Distribution of different fibre types in human skeletal muscles. 2. A study of cross-sections of whole m. vastus lateralis","volume":"117","author":"Lexell","year":"1983","journal-title":"Acta Physiol Scand"},{"key":"2026072012463745600_bib16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1748-1716.1982.tb07163.x","article-title":"The needle biopsy technique for fibre type determination in human skeletal muscle \u2013 a methodological study","volume":"116","author":"Blomstrand","year":"1982","journal-title":"Acta Physiol Scand"},{"key":"2026072012463745600_bib17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1748-1716.1989.tb08702.x","article-title":"Variability in muscle fibre areas in whole human quadriceps muscle. How much and why?","volume":"136","author":"Lexell","year":"1989","journal-title":"Acta Physiol Scand"},{"key":"2026072012463745600_bib18","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1152\/japplphysiol.00394.2024","article-title":"Does one biopsy cut it? Revisiting human muscle fiber type composition variability using repeated biopsies in the vastus lateralis and gastrocnemius medialis","volume":"137","author":"Van de Casteele","year":"2024","journal-title":"J Appl Physiol"},{"key":"2026072012463745600_bib19","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1210\/jc.2013-3059","article-title":"Reference intervals for insulin-like growth factor-1 (igf-i) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations","volume":"99","author":"Bidlingmaier","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026072012463745600_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2265.1983.tb03198.x","article-title":"Corticosteroid myopathy: a clinical and pathological study","volume":"18","author":"Khaleeli","year":"1983","journal-title":"Clin Endocrinol"},{"key":"2026072012463745600_bib21","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF03347462","article-title":"Steroid myopathy: some unresolved issues","volume":"34","author":"Minetto","year":"2011","journal-title":"J Endocrinol Investig"},{"key":"2026072012463745600_bib22","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.biocel.2013.05.036","article-title":"Glucocorticoid-induced skeletal muscle atrophy","volume":"45","author":"Schakman","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"2026072012463745600_bib23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nrd4467","article-title":"Muscle wasting in disease: molecular mechanisms and promising therapies","volume":"14","author":"Cohen","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"2026072012463745600_bib24","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1530\/EJE-10-1169","article-title":"Do muscle fiber conduction slowing and decreased levels of circulating muscle proteins represent sensitive markers of steroid myopathy? A pilot study in Cushing\u2019s disease","volume":"164","author":"Minetto","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"2026072012463745600_bib25","volume-title":"Muscle Biopsy: A Practical Approach","author":"Dubowitz","year":"2006","edition":"3rd edn"},{"key":"2026072012463745600_bib26","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1152\/japplphysiol.01362.2013","article-title":"Age-related structural alterations in human skeletal muscle fibers and mitochondria are sex specific: relationship to single-fiber function","volume":"116","author":"Callahan","year":"2014","journal-title":"J Appl Physiol"},{"key":"2026072012463745600_bib27","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.exger.2013.02.012","article-title":"The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size","volume":"48","author":"Nilwik","year":"2013","journal-title":"Exp Gerontol"},{"key":"2026072012463745600_bib28","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2165\/00007256-200434100-00004","article-title":"The role of resistance exercise intensity on muscle fibre adaptations","volume":"34","author":"Fry","year":"2004","journal-title":"Sports Med"},{"key":"2026072012463745600_bib29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1600-0838.2010.01196.x","article-title":"Effects of strength training on muscle fiber types and size; consequences for athletes training for high-intensity sport","volume":"20","author":"Andersen","year":"2010","journal-title":"Scand J Med Sci Sports"},{"key":"2026072012463745600_bib30","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nrendo.2013.183","article-title":"Glucocorticoid sensitivity in health and disease","volume":"9","author":"Quax","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"2026072012463745600_bib31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/1025389031000153658","article-title":"Glucocorticoid sensitivity in humans-interindividual differences and acute stress effects","volume":"6","author":"Rohleder","year":"2003","journal-title":"Stress"},{"key":"2026072012463745600_bib32","doi-asserted-by":"crossref","first-page":"L1","DOI":"10.1530\/EJE-19-0458","article-title":"IGF-1 and IGF-1 SDS \u2013 fit for purpose?","volume":"181","author":"Kos","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"2026072012463745600_bib33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1530\/eje.0.1440251","article-title":"Effects of short-term administration of low-dose rhGH on IGF-I levels in obesity and Cushing\u2019s syndrome: indirect evaluation of sensitivity to GH","volume":"144","author":"Maccario","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"2026072012463745600_bib34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1172\/JCI114694","article-title":"Human growth hormone prevents the protein catabolic side effects of prednisone in humans","volume":"86","author":"Horber","year":"1990","journal-title":"J Clin Investig"},{"key":"2026072012463745600_bib35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/(SICI)1097-4598(199902)22:2<213::AID-MUS9>3.0.CO;2-M","article-title":"Preventive effects of insulinlike growth factor-I on steroid-induced muscle atrophy","volume":"22","author":"Kanda","year":"1999","journal-title":"Muscle Nerve"},{"key":"2026072012463745600_bib36","doi-asserted-by":"crossref","first-page":"R34","DOI":"10.1152\/ajpregu.00177.2002","article-title":"Insulin-like growth factor I prevents corticosteroid-induced diaphragm muscle atrophy in emphysematous hamsters","volume":"285","author":"Fournier","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2026072012463745600_bib37","doi-asserted-by":"crossref","first-page":"987","DOI":"10.2165\/00007256-200838120-00003","article-title":"Cross-sectional area and muscular strength: a brief review","volume":"38","author":"Jones","year":"2008","journal-title":"Sports Med"},{"key":"2026072012463745600_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/03009748609092661","article-title":"Muscle biopsy in primary fibromyalgia. Light-microscopical and histochemical findings","volume":"15","author":"Bengtsson","year":"1986","journal-title":"Scand J Rheumatol"},{"key":"2026072012463745600_bib39","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3109\/17453678809148783","article-title":"Muscle changes in work-related chronic myalgia","volume":"59","author":"Larsson","year":"1988","journal-title":"Acta Orthop Scand"},{"key":"2026072012463745600_bib40","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1186\/s12967-023-04369-z","article-title":"Mitochondrial dysfunction: roles in skeletal muscle atrophy","volume":"21","author":"Chen","year":"2023","journal-title":"J Transl Med"},{"key":"2026072012463745600_bib41","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/ejendo\/lvad041","article-title":"Low-grade inflammation during the glucocorticoid withdrawal phase in patients with Cushing\u2019s syndrome","volume":"188","author":"Vogel","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"2026072012463745600_bib42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s11658-024-00572-y","article-title":"The role of mitochondrial dynamics and mitophagy in skeletal muscle atrophy: from molecular mechanisms to therapeutic insights","volume":"29","author":"Lei","year":"2024","journal-title":"Cell Mol Biol Lett"},{"key":"2026072012463745600_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.917113","article-title":"Diabetic muscular atrophy: molecular mechanisms and promising therapies","volume":"13","author":"Shen","year":"2022","journal-title":"Front Endocrinol"}],"container-title":["Endocrine Connections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-26-0355\/521795\/ec-26-0355.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-26-0355\/521795\/ec-26-0355.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T16:46:47Z","timestamp":1784566007000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article\/15\/7\/e260355\/77781\/Myopathy-in-endogenous-Cushing-s-syndrome-type-II"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1530\/ec-26-0355","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"article-number":"e260355"}}